P1031a (10042): Mother–Infant Rapid Intervention at Delivery (MIRIAD), International Version

Study Status Study Restriction


US & Non-US

What is P1031a?

P1031a was a prospective, cluster-randomized study of pregnant women with undocumented HIV serostatus who present for delivery at >28 weeks gestation and infants born to women with at least one positive rapid test result.  The study was designed to evaluate the feasibility, rate of acceptance, and acceptability of voluntary HIV counseling and rapid testing among pregnant women with undocumented HIV serostatus who present for delivery, and to compare intrapartum versus postpartum rapid testing, as well as to examine the rate of acceptance of ARV prophylaxis to women identified as seropositive and their infants.

Study documents:

Study contacts:

No records returned.

CTS: IMPAACT.OperationsCenter@fstrf.org


Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.